New insider activity at Cytokinetics ( (CYTK) ) has taken place on March 19, 2025.
EVP Research & Development Fady Ibraham Malik recently sold 2,000 shares of Cytokinetics stock, amounting to a total transaction value of $87,160.
More about Cytokinetics
YTD Price Performance: -8.22%
Average Trading Volume: 1,539,972
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $5.25B
Questions or Comments about the article? Write to editor@tipranks.com